Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.

Idiopathic Pulmonary Fibrosis Clinical Research Network, Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW.

N Engl J Med. 2010 Aug 12;363(7):620-8. doi: 10.1056/NEJMoa1002110. Epub 2010 May 18.

2.

Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation.

Saggar R, Shapiro SS, Ross DJ, Fishbein MC, Zisman DA, Lynch JP 3rd, Weigt SS, Ardehali A, Belperio JA, Saggar R.

J Heart Lung Transplant. 2009 Sep;28(9):964-7. doi: 10.1016/j.healun.2009.05.017.

PMID:
19716051
3.

Diagnosis and hemodynamic assessment of pulmonary arterial hypertension.

Saggar R, Saggar R, Aboulhosn J, Belperio JA, Zisman DA, Lynch JP 3rd.

Semin Respir Crit Care Med. 2009 Aug;30(4):399-410. doi: 10.1055/s-0029-1233309. Epub 2009 Jul 24. Review.

PMID:
19634079
4.

Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome.

Weigt SS, Elashoff RM, Huang C, Ardehali A, Gregson AL, Kubak B, Fishbein MC, Saggar R, Keane MP, Saggar R, Lynch JP 3rd, Zisman DA, Ross DJ, Belperio JA.

Am J Transplant. 2009 Aug;9(8):1903-11. doi: 10.1111/j.1600-6143.2009.02635.x. Epub 2009 May 13.

5.

CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis.

Busuttil A, Weigt SS, Keane MP, Xue YY, Palchevskiy V, Burdick MD, Huang C, Zisman DA, Fishbein M, Lynch JP 3rd, Strieter RM, Elashoff RM, Belperio JA.

Eur Respir J. 2009 Sep;34(3):676-86. doi: 10.1183/09031936.00157508. Epub 2009 Apr 22.

6.

Idiopathic pulmonary fibrosis: a shot through the heart?

Zisman DA, Kawut SM.

Am J Respir Crit Care Med. 2008 Dec 15;178(12):1192-3. doi: 10.1164/rccm.200808-1339ED. No abstract available.

PMID:
19050202
7.

Serum albumin concentration and waiting list mortality in idiopathic interstitial pneumonia.

Zisman DA, Kawut SM, Lederer DJ, Belperio JA, Lynch JP 3rd, Schwarz MI, Tayek JA, Reuben DB, Karlamangla AS.

Chest. 2009 Apr;135(4):929-935. doi: 10.1378/chest.08-0754. Epub 2008 Nov 18.

8.

Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft.

Saggar R, Ross DJ, Saggar R, Zisman DA, Gregson A, Lynch JP 3rd, Keane MP, Weigt SS, Ardehali A, Kubak B, Lai C, Elashoff D, Fishbein MC, Wallace WD, Belperio JA.

Am J Transplant. 2008 Sep;8(9):1921-30. doi: 10.1111/j.1600-6143.2008.02338.x. Epub 2008 Jul 28.

9.

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis.

Nathan SD, Shlobin OA, Barnett SD, Saggar R, Belperio JA, Ross DJ, Ahmad S, Saggar R, Libre E, Lynch JP 3rd, Zisman DA.

Respir Med. 2008 Sep;102(9):1305-10. doi: 10.1016/j.rmed.2008.03.022. Epub 2008 Jul 10.

10.

Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.

Weigt SS, Elashoff RM, Keane MP, Strieter RM, Gomperts BN, Xue YY, Ardehali A, Gregson AL, Kubak B, Fishbein MC, Saggar R, Ross DJ, Lynch JP 3rd, Zisman DA, Belperio JA.

Am J Transplant. 2008 Jul;8(7):1512-22. doi: 10.1111/j.1600-6143.2008.02280.x.

11.

Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Zisman DA, Karlamangla AS, Kawut SM, Shlobin OA, Saggar R, Ross DJ, Schwarz MI, Belperio JA, Ardehali A, Lynch JP 3rd, Nathan SD.

Chest. 2008 Mar;133(3):640-5. doi: 10.1378/chest.07-2488. Epub 2008 Jan 15.

12.

Idiopathic pulmonary fibrosis.

Lynch JP 3rd, Fishbein MC, Saggar R, Zisman DA, Belperio JA.

Expert Rev Respir Med. 2007 Dec;1(3):377-89. doi: 10.1586/17476348.1.3.377.

PMID:
20477177
13.

Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis.

Zisman DA, Ross DJ, Belperio JA, Saggar R, Lynch JP 3rd, Ardehali A, Karlamangla AS.

Respir Med. 2007 Oct;101(10):2153-9. Epub 2007 Jul 2.

14.

Acute exacerbations of idiopathic pulmonary fibrosis.

Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA, Raghu G, Roman J, Ryu JH, Zisman DA, Hunninghake GW, Colby TV, Egan JJ, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kondoh Y, Lynch DA, Müller-Quernheim J, Myers JL, Nicholson AG, Selman M, Toews GB, Wells AU, Martinez FJ; Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators.

Am J Respir Crit Care Med. 2007 Oct 1;176(7):636-43. Epub 2007 Jun 21. Review.

15.

High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R, Lynch JP 3rd, Ardehali A, Goldin J.

Chest. 2007 Sep;132(3):773-9. Epub 2007 Jun 15.

16.

Sildenafil improves walk distance in idiopathic pulmonary fibrosis.

Collard HR, Anstrom KJ, Schwarz MI, Zisman DA.

Chest. 2007 Mar;131(3):897-899. doi: 10.1378/chest.06-2101.

17.
18.

Usual interstitial pneumonia.

Lynch JP 3rd, Saggar R, Weigt SS, Zisman DA, White ES.

Semin Respir Crit Care Med. 2006 Dec;27(6):634-51. Review.

19.

IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.

Keane MP, Gomperts BN, Weigt S, Xue YY, Burdick MD, Nakamura H, Zisman DA, Ardehali A, Saggar R, Lynch JP 3rd, Hogaboam C, Kunkel SL, Lukacs NW, Ross DJ, Grusby MJ, Strieter RM, Belperio JA.

J Immunol. 2007 Jan 1;178(1):511-9.

20.

Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease.

Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM.

Biochem Biophys Res Commun. 2007 Feb 2;353(1):104-8. Epub 2006 Dec 11.

PMID:
17174272
21.

Transbronchial biopsy in usual interstitial pneumonia.

Berbescu EA, Katzenstein AL, Snow JL, Zisman DA.

Chest. 2006 May;129(5):1126-31.

22.

Pulmonary fibrosis.

Zisman DA, Keane MP, Belperio JA, Strieter RM, Lynch JP 3rd.

Methods Mol Med. 2005;117:3-44. Review.

PMID:
16130230
23.

Sarcoidosis involving the musculoskeletal system.

Zisman DA, Shorr AF, Lynch JP 3rd.

Semin Respir Crit Care Med. 2002 Dec;23(6):555-70.

PMID:
16088651
24.

CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.

Burdick MD, Murray LA, Keane MP, Xue YY, Zisman DA, Belperio JA, Strieter RM.

Am J Respir Crit Care Med. 2005 Feb 1;171(3):261-8. Epub 2004 Oct 22.

25.

Association between pulmonary fibrosis and coronary artery disease.

Kizer JR, Zisman DA, Blumenthal NP, Kotloff RM, Kimmel SE, Strieter RM, Arcasoy SM, Ferrari VA, Hansen-Flaschen J.

Arch Intern Med. 2004 Mar 8;164(5):551-6.

PMID:
15006833
26.

Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch JP 3rd.

Drugs. 2004;64(4):405-30. Review.

PMID:
14969575
27.

Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection.

Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Zisman DA, Xue YY, Li K, Ardehali A, Ross DJ, Strieter RM.

J Immunol. 2003 Nov 1;171(9):4844-52.

28.

Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.

Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM.

Am J Respir Crit Care Med. 2003 Mar 1;167(5):735-40. Epub 2002 Dec 12.

PMID:
12480614
29.

Usual interstitial pneumonia: histologic study of biopsy and explant specimens.

Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM.

Am J Surg Pathol. 2002 Dec;26(12):1567-77.

PMID:
12459623
30.

Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome.

Szeto WY, Kreisel D, Karakousis GC, Pochettino A, Sterman DH, Kotloff RM, Arcasoy SM, Zisman DA, Blumenthal NP, Gallop RJ, Kaiser LR, Bavaria JE, Rosengard BR.

J Thorac Cardiovasc Surg. 2002 Aug;124(2):241-9.

31.

Drug-induced pneumonitis: the role of methotrexate.

Zisman DA, McCune WJ, Tino G, Lynch JP 3rd.

Sarcoidosis Vasc Diffuse Lung Dis. 2001 Oct;18(3):243-52. Review.

PMID:
11587095
32.

Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids.

Zisman DA, Lynch JP 3rd, Toews GB, Kazerooni EA, Flint A, Martinez FJ.

Chest. 2000 Jun;117(6):1619-26.

PMID:
10858393
33.

Sarcoidosis presenting as a tumorlike muscular lesion. Case report and review of the literature.

Zisman DA, Biermann JS, Martinez FJ, Devaney KO, Lynch JP 3rd.

Medicine (Baltimore). 1999 Mar;78(2):112-22. Review.

34.

Ethanol feeding impairs innate immunity and alters the expression of Th1- and Th2-phenotype cytokines in murine Klebsiella pneumonia.

Zisman DA, Strieter RM, Kunkel SL, Tsai WC, Wilkowski JM, Bucknell KA, Standiford TJ.

Alcohol Clin Exp Res. 1998 May;22(3):621-7.

35.

Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.

Zisman DA, Kunkel SL, Strieter RM, Gauldie J, Tsai WC, Bramson J, Wilkowski JM, Bucknell KA, Standiford TJ.

Shock. 1997 Nov;8(5):349-56.

PMID:
9361345
36.

MCP-1 protects mice in lethal endotoxemia.

Zisman DA, Kunkel SL, Strieter RM, Tsai WC, Bucknell K, Wilkowski J, Standiford TJ.

J Clin Invest. 1997 Jun 15;99(12):2832-6.

37.

Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae.

Tsai WC, Strieter RM, Zisman DA, Wilkowski JM, Bucknell KA, Chen GH, Standiford TJ.

Infect Immun. 1997 May;65(5):1870-5.

Supplemental Content

Loading ...
Support Center